Crizonix (Crizotinib) - 250mg (28 Capsules)

Crizonix

CRIZOTINIB

* Our best price : £ 2021.81

Crizonix contains the cancer drug Crizotinib, a kinase inhibitor indicated in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive.

Brand Name : Crizonix
Active Ingredients : CRIZOTINIB
Manufacturer : Beacon Pharmaceuticals Limted
Country of Origin : Bangladesh
Intended Patient : Unisex

Customers also like

Crizonix (Crizotinib) - 250mg (28 Capsules) Crizonix (Crizotinib) - 250mg (28 Capsules)
Out of stock
* Quantity
1 Pack +
Price / Each
£2021.81

Description


Main Use Active Ingredient Marketed Name
Metastatic non-small cell lung cancer Crizotinib Crizonix

Uses
Crizonix contains the cancer drug Crizotinib, a kinase inhibitor indicated in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive. Crizotinib is FDA-approved as a therapy for both ALK positive and ROS1-positive metastatic NSCLC. It is the only FDA approved drug for ROS 1 positive NSCLC.

Dosage and Administration
Each pack of Crizonix contains 28 x 250mg capsules.

Your doctor will prescribe you a specific dose. Your doctor should also advise how often to take Crizotinib, when to take Crizotinib and how long to take Crizotinib for.

Precautions
Crizonix can be used by:

  • adults with ALK-positive advanced NSCLC (non-small cell lung cancer)
  • adults with previously treated ALK-positive advanced NSCLC & ROS1 (+) NSCLC

This product is added. Thank you.

 Please choose your option:

0
My Cart : 0 Items £0.00

Shopping Cart

 

Your cart is empty